Vir Biotechnology Reminds Stockholders of 2022 Annual General Meeting Details
May 18 2022 - 4:03PM
Vir Biotechnology, Inc. (Nasdaq: VIR) today reminds stockholders
that it will hold its 2022 Annual General Meeting of Stockholders
on Friday, May 20, 2022, at 11:30 a.m. PT. The Annual Meeting will
be held in virtual format only via live audio webcast.
Vir Biotechnology’s stockholders of record as of
March 28, 2022 (the “Record Date”) can attend and vote at the
Annual Meeting by accessing the meeting center at
www.virtualshareholdermeeting.com/VIR2022 and entering the control
number on the proxy card or Notice of Internet Availability of
Proxy Materials previously received. Instructions on how to connect
to the Annual Meeting and participate via the Internet are also
posted at www.virtualshareholdermeeting.com/VIR2022. Online access
to the Annual Meeting will begin at 11:15 a.m. PT. Stockholders
should allow ample time for the check-in procedures.
Whether or not stockholders plan to virtually
attend the Annual Meeting, Vir Biotechnology urges them to vote and
submit their proxy in advance of the Annual Meeting by one of the
methods described in the proxy materials for the Annual
Meeting.
About Vir BiotechnologyVir
Biotechnology is a commercial-stage immunology company focused
on combining immunologic insights with cutting-edge technologies to
treat and prevent serious infectious diseases. Vir has assembled
four technology platforms that are designed to stimulate and
enhance the immune system by exploiting critical observations of
natural immune processes. Its current development pipeline consists
of product candidates targeting COVID-19, hepatitis B and hepatitis
D viruses, influenza A and human immunodeficiency virus. Vir
routinely posts information that may be important to investors on
its website.
Contacts:
Investors
Heather Rowe Armstrong
VP, Investor Relations
harmstrong@vir.bio
+1-415-915-4228
Media
Cara Miller
VP, Corporate Communications
cmiller@vir.bio
+1-415-941-6746
Vir Biotechnology (NASDAQ:VIR)
Historical Stock Chart
From Mar 2024 to Apr 2024
Vir Biotechnology (NASDAQ:VIR)
Historical Stock Chart
From Apr 2023 to Apr 2024